VistaGen Therapeutics, Inc.
VTGN
$2.22
-$0.12-5.13%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 88.56M | 97.58M | 108.36M | 119.17M | 126.56M |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 1.38M | 2.37M | 2.47M | 1.43M | 1.48M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | 74.00K | 74.50K |
| Total Current Assets | 89.94M | 99.95M | 110.84M | 120.67M | 128.11M |
|
|
|||||
| Total Current Assets | 89.94M | 99.95M | 110.84M | 120.67M | 128.11M |
| Net Property, Plant & Equipment | 1.89M | 2.05M | 2.19M | 2.26M | 2.38M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 477.00K | 498.00K | 518.00K | 726.00K | 575.30K |
| Total Assets | 92.31M | 102.50M | 113.55M | 123.65M | 131.07M |
|
|
|||||
| Total Accounts Payable | 1.04M | 715.00K | 1.21M | 1.55M | 1.74M |
| Total Accrued Expenses | 5.47M | 3.82M | 2.16M | 2.24M | 129.30K |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 603.00K | 525.00K | 567.00K | 550.00K | 535.40K |
| Total Finance Division Other Current Liabilities | 2.51M | 2.47M | 2.30M | 791.00K | 1.76M |
| Total Other Current Liabilities | 2.51M | 2.47M | 2.30M | 791.00K | 1.76M |
| Total Current Liabilities | 9.62M | 7.52M | 6.24M | 5.12M | 4.16M |
|
|
|||||
| Total Current Liabilities | 9.62M | 7.52M | 6.24M | 5.12M | 4.16M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 1.11M | 1.27M | 1.42M | 1.57M | 1.72M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 454.00K | 730.00K | 1.09M | 2.67M | 1.90M |
| Total Liabilities | 11.19M | 9.52M | 8.75M | 9.37M | 7.78M |
|
|
|||||
| Common Stock & APIC | 479.08M | 476.83M | 475.72M | 474.47M | 473.95M |
| Retained Earnings | -394.00M | -379.91M | -366.95M | -356.21M | -346.69M |
| Treasury Stock & Other | -3.96M | -3.95M | -3.97M | -3.97M | -3.97M |
| Total Common Equity | 81.12M | 92.97M | 104.80M | 114.29M | 123.28M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 81.12M | 92.97M | 104.80M | 114.29M | 123.28M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 81.12M | 92.97M | 104.80M | 114.29M | 123.28M |
|
|
|||||